Serum levels of erythropoietin in acute Plasmodium falciparum malaria

American Journal of Tropical Medicine and Hygiene

Volumn 54, Issue 3, 1996, Pages 280-283

  Burgmann, H ^a   Looareesuwan, S ^b   Kapiotis, S ^a   Viravan, C ^b   Vanijanonta, S ^b   Hollenstein, U ^a   Wiesinger, E ^a   Presterl, E ^a   Winkler, S ^a   Graninger, W ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ARTEMISIN DERIVATIVE; ARTESUNATE; ERYTHROPOIETIN;

ANEMIA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROPOIESIS; HEMATOCRIT; HEMATOLOGICAL PARAMETERS; HOST PARASITE INTERACTION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALARIA FALCIPARUM; PLASMODIUM FALCIPARUM;

EID: 13344281007     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.1996.54.280     Document Type: Article

References (29)

1. Phillips RE, Pasvol G, 1992. Anaemia of Plasmodium falciparum malaria. Baillieres Clin Haematol 5: 315-330.
2. Phillips RE, Looareesuwan S, Warrell DA, Let SH, Karewang J, Warrell MJ, White NI, Swasdichai C, Weatherall DJ, 1986. The importance of anaemia in cerebral and uncomplicated falciparum malaria: role of complications, dyserythropoiesis and iron sequestration. Q J Med 58: 305-323.
3. Woodruff AW, Ansdell VE, Pettitt LL, 1979. Cause of anaemia in malaria. Lancet i: 1055-1057.
4. Dormer P, Dietrich M, Kern P, Horstmann RD, 1983. Ineffective erythropoiesis in acute human P. falciparum malaria. Blut 46: 279-288.
5. Silverman PH, Schooley JC, Mahlmann LJ, 1987. Murine malaria decreases hemopoietic stem cells. Blood 69: 408-413.
6. Abdalla SH, 1990. Hematopoiesis in human malaria. Blood Cells 16: 401-416.
7. Wickramasinghe SN, Looareesuwan S, Nagachinta B, White NJ, 1989. Dyserythropoiesis and ineffective erythropoiesis in Plasmodium vivax malaria. Br J Haematol 72: 91-99.
8. Miller KL, Silverman PH, Kullgren B, Mahlmann LJ, 1989. Tumor necrosis factor alpha and the anemia associated with murine malaria. Infect Immun 57: 1542-1546.
9. Kern P, Hemmer CJ, Gallati H, Neifer S, Kremsner P, Dietrich M, Porzsolt F, 1992. Soluble tumor necrosis factor receptors correlate with parasitemia and disease severity in human malaria (published erratum appears in J Infect Dis 1992 166: 1467). J Infect Dis 166: 930-934.
10. Miller KL, Schooiey JC, Smith KL, Kullgren B, Mahlmann LJ, Silverman PH, 1989. Inhibition of erythropoiesis by a soluble factor in murine malaria. Exp Hematol 17: 379-385.
11. Sherwood JB, 1984. The chemistry and physiology of erythropoietin. Vitam Horm 41: 161-211.
12. Eschbach JW, 1991. Erythropoietin 1991-an overview. Am J Kidney Dis 18: 3-9.
13. Spivak JL, 1986. The mechanism of action of erythropoietin. Int J Cell Cloning 4: 139-166.
14. Cazzola M, Beguin Y, 1992. New tools for clinical evaluation of erythron function in man. Br J Haematol 80: 278-284.
15. Warrell DA, Molyneux ME, Beales PF, 1990. Severe and complicated malaria. Trans R Soc Trop Med Hys 84 (suppl 2): 1-65.
16. Jootar S, Chaisiripoomkere W, Pholvicha P, Leelasiri A, Prayoonwiwat W, Mongkonsvitragoon W, Srichaikul T, 1993. Suppression of erythroid progenitor cells during malarial infection in Thai adults caused by serum inhibitor. Clin Lab Haematol 15: 87-92.
17. el Shoura SM, 1993. Falciparum malaria in naturally infected human patients: IV. Ultrastructural changes in peripheral white blood cells. Ann Parasitol Hum Comp 68: 169-175.
18. Asami M, Abe T, Owhashi M, Nawa Y, 1992. Appearance of adherent cells suppressive to erythropoiesis during an early stage of Plasmodium berghei infection in mice. Southeast Asian J Trop Med Public Health 23: 184-188.
19. Shull RM, Suggs SV, Langley KE, Okino KH, Jacobsen FW, Martin FH, 1992. Canine stem cell factor (c-kit ligand) supporta the survival of hematopoietic progenitors in long-term canine marrow culture. Exp Haematol 20: 1118-1124.
20. Clark IA, Chaudhri G, 1988. Tumor necrosis factor may contribute to the anaemia of malaria by causing dyserythropoiesis and erythrophagocytosis. Br J Haematol 70: 99-103.
21. Rockett KA, Awburn MM, Rockett LJ, Clark IA, 1994. Tumor necrosis factor and interleukin-1 synergy in the context of malaria pathology. Am J Trop Med Hyg 50: 735-742.
22. Clark IA, Cowden WB, 1992. Roles of TNF in malaria and other parasitic infections. Immunol Ser 56: 365-407.
23. Yap YS, Stevenson MM, 1994. Inhibition of in vitro erythropoiesis by soluble mediators in Plasmodium chabaudi AS malaria: lack of a major role for interleukin 1, tumor necrosis factor alpha, and gamma mterferon. Infect Immun 62: 357-362.
24. Marsden JT, Sherwood RA, Hillis A, Peters TJ, 1993. Monitoring erythropoietin therapy for anaemia of chronic renal failure by serum erythropoietin assays. Ann Clin Biochem 30: 205-206.
25. Baer AN, Dessypris EN, Goldwasser E, Krantz SB, 1987. Blunted erythropoietin response to anaemia in rheumatoid arthritis. Br J Haematol 66: 559-564.
26. Spivak JL, Barnes DC, Fuchs E, Quinn TC, 1989. Serum immunoreactive erythropoietin in HIV-infected patients. JAMA 261: 3104-3107.
27. Sherwood JB, Goldwasser E, Chilcote R, Carmichael LD, Nagel RL, 1986. Sickle cell anemia patients have low erythropoietin levels for their degree of anemia. Blood 67: 46-49.
28. Yap YS, Stevenson MM, 1991. Production of soluble inhibitor of erythropoiesis during Plasmodium chabaudi AS infection in resistant and susceptible mice. Ann NY Acad Sci 628: 279-281.
29. Burgmann H, Hollenstein U, Wenisch C, Thalhammer F, Looareesuwan S, Graninger W, 1995. Serum concentrations of MTP-1 alpha and interleukin-8 in patients suffering from acute Plasmodium falciparum malaria. Clin Immunol Immunopathol 75: 32-36.